Provided herein are methods of treatment of individuals having schizophrenia, or schizophreniform disorder, using angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of and compositions comprising, such cells. A need exists for therapies that can ameliorate or palliate schizophrenia, or a schizophreniform disorder, or symptoms of the same. Provided herein are methods of treating individuals who have schizophrenia, or schizophreniform disorder, comprising administration of therapeutically-effective amounts (numbers) of AMDACs.
